Characteristics and conflicts of public speakers at meetings of the oncologic drugs advisory committee to the US food and drug administration

Matthew V. Abola, Vinay Prasad

Research output: Contribution to journalArticle

12 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)389-391
Number of pages3
JournalJAMA Internal Medicine
Volume176
Issue number3
DOIs
StatePublished - Mar 1 2016

Fingerprint

Pharmacy and Therapeutics Committee
Drug Approval
Conflict of Interest
Medicaid
Drug Industry
Advisory Committees
United States Food and Drug Administration
Medicare
Antineoplastic Agents

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Characteristics and conflicts of public speakers at meetings of the oncologic drugs advisory committee to the US food and drug administration. / Abola, Matthew V.; Prasad, Vinay.

In: JAMA Internal Medicine, Vol. 176, No. 3, 01.03.2016, p. 389-391.

Research output: Contribution to journalArticle

@article{0a7915ca82f2475f9dafecf99ef8dbf7,
title = "Characteristics and conflicts of public speakers at meetings of the oncologic drugs advisory committee to the US food and drug administration",
author = "Abola, {Matthew V.} and Vinay Prasad",
year = "2016",
month = "3",
day = "1",
doi = "10.1001/jamainternmed.2015.7805",
language = "English (US)",
volume = "176",
pages = "389--391",
journal = "JAMA Internal Medicine",
issn = "2168-6106",
publisher = "American Medical Association",
number = "3",

}

TY - JOUR

T1 - Characteristics and conflicts of public speakers at meetings of the oncologic drugs advisory committee to the US food and drug administration

AU - Abola, Matthew V.

AU - Prasad, Vinay

PY - 2016/3/1

Y1 - 2016/3/1

UR - http://www.scopus.com/inward/record.url?scp=84962142294&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84962142294&partnerID=8YFLogxK

U2 - 10.1001/jamainternmed.2015.7805

DO - 10.1001/jamainternmed.2015.7805

M3 - Article

VL - 176

SP - 389

EP - 391

JO - JAMA Internal Medicine

JF - JAMA Internal Medicine

SN - 2168-6106

IS - 3

ER -